Biorbis Antibody Engineering and Design Conference and Workshops
Antibody Engineering and Design USA
Accelerating Progress in Antibody Drug Development
Conference: July 28th/29th 2010 | Pre-conference Workshops: July 27th | Boston, Massachusetts, USA
The world's first and only antibody event designed by you...
World leading speakers |
||
![]() |
![]() |
![]() |
| Dr Davinder Gill Vice President, Global Biologics Technologies Group Pfizer |
Dr Zhenping Zhu Vice President and Global Head, Protein Sciences Novartis |
Dr William Strohl Vice President, Biologics Research Johnson & Johnson |
![]() |
![]() |
![]() |
| Dr Robert Beckman Executive Director, Clinical Research Oncology Daiichi-Sankyo |
Dr Tristan Vaughan Senior Director, Lead Generation MedImmune |
Dr Chung-Ming Hsieh Senior Group Leader, Biologics Research Abbott |
![]() |
![]() |
![]() |
| Dr Daniel Lightwood Senior Group Leader, Antibody Discovery UCB-Celltech |
Dr Robert Kelley Senior Scientist, Antibody Engineering Genentech |
Dr Vahe Bedian Director, Biotherapeutics AstraZeneca |
![]() |
![]() |
![]() |
| Dr Randy Brezski Research Scientist, Fc Engineering Centocor |
Dr Jennifer Michaelson Principal Scientist, Molecular Discovery Biogen Idec |
Prof Dane Wittrup Professor of Chemical Engineering and Bioengineering MIT |
![]() |
![]() |
![]() |
| Dr Ira Pastan Chief, Laboratory of Molecular Biology NIH |
Dr Janice Reichert Senior Research Fellow, Tufts, Editor-in-Chief mAbs |
Dr Dimiter Dimitrov Senior Investigator, Protein Interaction Group NCI |
![]() |
![]() |
![]() |
| Dr Jim Mo Research Fellow, Analytical Research and Development Pfizer |
Dr Jijie Gu Principal Scientist, Biologics Research Abbott |
Dr Linda Engle Principal Scientist, Discovery (Adnexus) a BMS company |
![]() |
Dr Horacio Nastri, Head, Antibody Technologies, EMD Serono | Dr Barbara Rellahan, Principal Investigator, Division of Monoclonal Antibodies FDA |
| Dr Ryan Fiorini Chief Operating Officer Immunologix |
||
|
||
The Biorbis Antibody Engineering & Design, USA conference is a new breed of antibody meeting, different to any other you've experienced.
Because it's been designed by you.
It's been designed by people from companies like Genentech, MedImmune, Roche, Abbott, Johnson & Johnson, Biogen Idec, Merck, UCB Celltech, Pfizer and many other big pharmaceutical companies and innovative biotechs.
Why attend?
Shorn of tired case studies and company overviews, the focus is on delivering practical value to your antibody drug development activities.
Covering challenges and opportunities identified by you, you'll leave this meeting with a raft of new ideas and contacts to take back to your organization.
Hear speakers talk about overcoming problems you're facing with a level of frankness and sincerity you can't get from any other antibody event.
Meet innovative scientists and research leaders from big pharma and large biotech, and understand how they meet the challenges associated with engineering and designing more effective antibody drugs.
What's on the agenda?
Here are just some of topics covered on the agenda:
- Engineering antibodies with enhanced characteristics. Isotype choice, half life, stability, efficacy, immunogenicity, using structural insights and more…
- Utilizing structural-based drug design. How to enhance structural understanding, epitope mapping and using crystallization studies to improve subsequent development
- Reduction of manufacturing risk and improving expression early in the development process
- How to ensure appropriate species cross-reactivity
- How to improve anti-tumour activity through better antibody design. The thoughts of several of the world's leading oncology experts and case studies
- Generation of multivalent antibodies and use combinatorial strategies to combat cancer
- Discovery of suitable antibody candidates and identification new targets via novel strategies
- Exploiting the potential of immunodrug conjugates as an emerging therapeutic
1-2-1 Partnering
We work harder than any other meeting organizer to put you in front of the individuals you want to meet, providing personal introductions and a host of other networking opportunities including:
- Speed networking – Meet up to 50 other attendees in a one hour session. Introduce yourself to potential partners, collaborators and clients.
- Over 8 hours of networking time built into the agenda
- Innovative masterclasses providing you with the chance to get tailored solutions to the challenges you're facing.
- Panel discussion – interactive Q&A sessions giving you an opportunity to join the discussion.






































